) recently secured an order from Trinity Health for its Unified
Clinical Organization (UCO) model designed to improve care
co-ordination and patient outcomes.
In accordance with the agreement, Accenture provided a
standardized platform to increase the efficiency in Trinity's IT
system, advancing its clinical and disease management processes
across 49 Trinity hospitals.
This has enhanced the modern life saving process, as it has
resulted in an 18.0% reduction in mortality rates, saving a total
of 400 lives due to proactive management.
Competition is close on its heels however, with tech behemoths
), as well as a host of smaller players looking for a share of
the healthcare market. Given the size and growth prospects of the
healthcare market and the scope for technology purchases in the
segment, Accenture should be able to carve out its own niche.
Over the last decade, Accenture has successfully won many
deals across different product categories. However, we believe
that it is time for the company to focus on deals with higher
margins. A series of contract wins at the beginning of 2013 is
certainly a good start for Accenture.
Although cloud-based solutions provided by Accenture seem to
be in demand for companies across the world, post implementation
challenges faced by different companies may be a cause of concern
for this leading global IT company. This may have an impact on
the real-time client output and efficiency. At times, companies
incur financial and business losses for not having a customized
Currently, Accenture has a Zacks Rank #3 (Hold). Investors may
also look into other technology stocks, which are better
positioned such as
) with a Zacks Rank #1 (Strong Buy).
ACCENTURE PLC (ACN): Free Stock Analysis
CORELOGIC INC (CLGX): Free Stock Analysis
DELL INC (DELL): Free Stock Analysis Report
INTL BUS MACH (IBM): Free Stock Analysis
To read this article on Zacks.com click here.